Why GlaxoSmithKline plc, Resolution Limited And Rio Tinto plc Should Beat The FTSE 100 Today

GlaxoSmithKline plc (LON: GSK), Resolution Limited (LON: RSL) and Rio Tinto plc (LON: RIO) are on the way up.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Finally, we have a bit of life in the FTSE 100 (FTSEINDICES: ^FTSE), with the UK’s main index up 32 points to 6,606 by late morning. The insurance sector is putting in a good day so far, and the recent mini-recovery among the miners has not run out of steam. UK inflation for July was pretty much bang on expectations too, which helped steady nerves.

But which shares are on the way up? Here are three helping support the FTSE 100 today:

GlaxoSmithKline

GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) shares gained 20.7p (1.2%) to 1,686p this morning on the news that the HIV treatment Tivicay has been given approval by the US Food and Drug Administration in 50mg tablet form. The drug is made by HIV specialist ViiV Healthcare, which is part-owned by GlaxoSmithKline, and the approval comes after a number of phase III trials.

GlaxoSmithKline shares have recovered well from a pessimistic 2012, though the price has been erratic of late — but it’s still up around 13% over the past 12 months. Based on forecasts for the year to December, the shares are on a P/E of a distinctly average 14, with a predicted 4.4% dividend yield on offer.

Resolution

First-half results sent Resolution shares up 11p (3.4%) to 335p, taking them up more than 50% over the past year. The life insurer saw pre-tax profit rise 17% £191m, with earnings per share (EPS) also up by 17%, to 13.26p. The firm, however, kept its interim dividend stable at 7.05p per share.

The gains were largely driven by new business in the UK, which rose by 41% to £89m. Internationally, things remained stable, with new business coming in at £21m against £22m a year previously. Chief executive Andy Briggs said that “We continue to make excellent operational progress in line with the clear and consistent strategy and value agenda of the Group“.

Rio Tinto

The recent rise in Chinese factory output has given the mining sector a boost this week, and Rio Tinto (LSE: RIO) (NYSE: RIO.US) gave us one of the biggest FTSE 100 risers by the time of writing today, with its shares up a further 64p (2%) to 3,257p. The shares had been on a slump since the start of 2013, losing around 30% between February’s peak and late June. But in the six weeks since, the price is back up 26% to bring it pretty much flat over the past 12 months.

There’s a small fall in EPS forecast for the full year, but a predicted return to earnings growth in 2014 would drop the P/E down to under 9. Meanwhile, there’s a likely dividend yield of around 3.7% on offer.

Finally, if you’re looking for investments that should take you all the way to a comfortable retirement, I recommend the Fool’s special new report detailing five blue-chip shares. They’ll be familiar names to many, and they’ve already provided investors with decades of profits.

But the report will only be available for a limited period, so click here to get your hands on these great ideas — they could set you on the road to long-term riches.

> Alan does not own any shares mentioned in this article. The Motley Fool has recommended shares in GlaxoSmithKline.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »